Organizations in the UK come together to support the scale-up of cell therapies to help reach more patients.
Three UK sites were awarded funding to form a network of advanced therapy treatment centres – joint ventures funded by Innovate UK, and comprised of industry, academic and NHS partners. The centres; Innovate Manchester Advanced Therapy Centre Hub (iMATCH), the Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC, comprising Birmingham, Wales and Nottingham) and the Northern Alliance Advanced Therapies Treatment Centre (NAATTC, comprising Scotland, Newcastle and Leeds) will specialize in the delivery of cell and gene therapy products.
GE is proud to be part of these collaborations.
Read more about this announcement in the following related press releases:
Innovate Manchester Advanced Therapy Centre Hub (iMATCH): Multi-million pound government award to Manchester health consortium.
Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC): Multi-million pound award aims to create new breakthrough therapies.
Northern Alliance Advanced Therapies Treatment Centre (NAATTC): A Northern Alliance wins £7m Advanced Therapies Treatment Centre bid.
Celland Gene Therapy (CGT) Catapult: CGT Catapult to support UK network of Advanced Therapies Treatment Centres
Related topics from GE: